Klarsen reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.871 million compared to EUR 0.834 million a year ago. Net income was EUR 0.163 million compared to EUR 0.157 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.642 EUR | -3.98% | -0.73% | -39.63% |
04-30 | Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
1st Jan change | Capi. | |
---|---|---|
-39.63% | 6.18M | |
-8.24% | 199B | |
+10.15% | 181B | |
+13.47% | 168B | |
+4.92% | 99.31B | |
+45.84% | 91.84B | |
+14.08% | 85.57B | |
+11.87% | 84.59B | |
+7.06% | 50.83B | |
-31.98% | 44.78B |
- Stock Market
- Equities
- ALKLA Stock
- News Klarsen
- Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022